Search research articles
Contact Us
Filters
Showing results (141-150 of 178) with videos related to
Page
of 18
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 30, 2007
A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
Cindy Zadikoff, Susan H Fox, David F Tang-Wai, et al.
Brain Communications
|
March 26, 2026
Distinct neuroinflammatory profiles in progressive supranuclear palsy associated with <i>HLA</i> haplotypes
Shelley L Forrest, Sarah S Zaheer, Ain Kim, et al.
Journal of Neurochemistry
|
April 16, 2008
Striatal histone modifications in models of levodopa-induced dyskinesia
Anthony P Nicholas, Farah D Lubin, Penelope J Hallett, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations
Sang Soo Cho, Antonio P Strafella, Sarah Duff-Canning, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 6, 2011
The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease
James B Koprich, Susan H Fox, Tom H Johnston, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 17, 2025
Frozen in Addiction: A New Wave of Drug-Induced Movement Disorders?
Christos Ganos, Roberto Erro, Mohammad Abdullah, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 22, 2018
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
Tom H Johnston, Michal Geva, Lilach Steiner, et al.
Neuropharmacology
|
June 18, 2013
TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque
Tom H Johnston, Philippe Huot, Susan H Fox, et al.
Plos One
|
March 26, 2013
Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+,K+-ATPase α3 missense mutant mice
Greer S Kirshenbaum, Neil Dawson, Jonathan G L Mullins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 25, 2023
The Pain in Dystonia Scale (PIDS)-Development and Validation in Cervical Dystonia
Veronica Bruno, Beatrice Achen, Francesca Morgante, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 178) with videos related to
Sort By:
Page
of 18
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 30, 2007
A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
Cindy Zadikoff, Susan H Fox, David F Tang-Wai, et al.
Brain Communications
|
March 26, 2026
Distinct neuroinflammatory profiles in progressive supranuclear palsy associated with <i>HLA</i> haplotypes
Shelley L Forrest, Sarah S Zaheer, Ain Kim, et al.
Journal of Neurochemistry
|
April 16, 2008
Striatal histone modifications in models of levodopa-induced dyskinesia
Anthony P Nicholas, Farah D Lubin, Penelope J Hallett, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations
Sang Soo Cho, Antonio P Strafella, Sarah Duff-Canning, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 6, 2011
The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease
James B Koprich, Susan H Fox, Tom H Johnston, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 17, 2025
Frozen in Addiction: A New Wave of Drug-Induced Movement Disorders?
Christos Ganos, Roberto Erro, Mohammad Abdullah, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 22, 2018
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
Tom H Johnston, Michal Geva, Lilach Steiner, et al.
Neuropharmacology
|
June 18, 2013
TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque
Tom H Johnston, Philippe Huot, Susan H Fox, et al.
Plos One
|
March 26, 2013
Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+,K+-ATPase α3 missense mutant mice
Greer S Kirshenbaum, Neil Dawson, Jonathan G L Mullins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 25, 2023
The Pain in Dystonia Scale (PIDS)-Development and Validation in Cervical Dystonia
Veronica Bruno, Beatrice Achen, Francesca Morgante, et al.
Page
of 18